LS Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.53M Sell
4,611
-326
-7% -$333K 0.75% 39
2026
Q1
$4.54M Buy
4,937
+2,948
+148% +$2.99M 0.68% 41
2025
Q4
$2.14M Buy
1,989
+213
+12% +$204K 0.3% 51
2025
Q3
$1.36M Sell
1,776
-354
-17% -$263K 0.19% 68
2025
Q2
$1.66M Sell
2,130
-210
-9% -$163K 0.24% 60
2025
Q1
$1.93M Buy
2,340
+40
+2% +$33.3K 0.3% 55
2024
Q4
$1.78M Buy
2,300
+20
+0.9% +$16.6K 0.26% 58
2024
Q3
$2.02M Sell
2,280
-77
-3% -$69.2K 0.3% 57
2024
Q2
$2.13M Sell
2,357
-27
-1% -$21.6K 0.33% 58
2024
Q1
$1.85M Sell
2,384
-1
-0% -$712 0.29% 62
2023
Q4
$1.39M Buy
2,385
+1,000
+72% +$584K 0.24% 67
2023
Q3
$744K Hold
1,385
0.14% 81
2023
Q2
$650K Hold
1,385
0.11% 85
2023
Q1
$476K Hold
1,385
0.09% 101
2022
Q4
$507K Hold
1,385
0.1% 94
2022
Q3
$448K Hold
1,385
0.09% 87
2022
Q2
$449K Hold
1,385
0.08% 95
2022
Q1
$397K Sell
1,385
-24
-2% -$6.18K 0.06% 104
2021
Q4
$389K Sell
1,409
-845
-37% -$214K 0.06% 108
2021
Q3
$521K Sell
2,254
-255
-10% -$62.9K 0.07% 103
2021
Q2
$576K Sell
2,509
-21,950
-90% -$4.41M 0.07% 102
2021
Q1
$4.57M Sell
24,459
-8,243
-25% -$1.61M 0.25% 105
2020
Q4
$5.52M Sell
32,702
-565
-2% -$84.4K 0.29% 90
2020
Q3
$4.92M Buy
33,267
+495
+2% +$76.6K 0.28% 88
2020
Q2
$5.38M Buy
32,772
+5,725
+21% +$879K 0.33% 74
2020
Q1
$3.75M Buy
27,047
+63
+0.2% +$8.66K 0.27% 90
2019
Q4
$3.55M Sell
26,984
-5,642
-17% -$654K 0.19% 117
2019
Q3
$3.65M Buy
32,626
+188
+0.6% +$20.9K 0.21% 110
2019
Q2
$3.59M Buy
32,438
+1,919
+6% +$226K 0.22% 107
2019
Q1
$3.96M Buy
30,519
+6,682
+28% +$813K 0.25% 99
2018
Q4
$2.76M Sell
23,837
-3,699
-13% -$413K 0.19% 116
2018
Q3
$2.96M Sell
27,536
-3,732
-12% -$373K 0.17% 127
2018
Q2
$2.67M Buy
31,268
+10,360
+50% +$851K 0.16% 134
2018
Q1
$1.62M Sell
20,908
-437
-2% -$35.2K 0.1% 219
2017
Q4
$1.8M Sell
21,345
-154
-0.7% -$13.1K 0.1% 195
2017
Q3
$1.84M Sell
21,499
-13,666
-39% -$1.12M 0.11% 180
2017
Q2
$2.89M Buy
35,165
+544
+2% +$44.4K 0.18% 121
2017
Q1
$2.91M Buy
34,621
+4,374
+14% +$350K 0.19% 116
2016
Q4
$2.23M Sell
30,247
-2,225
-7% -$166K 0.16% 132
2016
Q3
$2.61M Sell
32,472
-2,670
-8% -$214K 0.19% 106
2016
Q2
$2.77M Buy
35,142
+614
+2% +$46.2K 0.19% 114
2016
Q1
$2.49M Buy
34,528
+979
+3% +$74.1K 0.19% 117
2015
Q4
$2.83M Buy
33,549
+3,943
+13% +$327K 0.22% 95
2015
Q3
$2.48M Sell
29,606
-13,730
-32% -$1.16M 0.2% 99
2015
Q2
$3.62M Buy
43,336
+13,060
+43% +$995K 0.27% 77
2015
Q1
$2.2M Buy
30,276
+2,995
+11% +$213K 0.17% 131
2014
Q4
$1.88M Sell
27,281
-2,878
-10% -$194K 0.15% 147
2014
Q3
$1.96M Sell
30,159
-584
-2% -$37K 0.17% 126
2014
Q2
$1.91M Sell
30,743
-18,870
-38% -$1.13M 0.16% 126
2014
Q1
$2.92M Buy
49,613
+33,143
+201% +$1.85M 0.24% 88
2013
Q4
$840K Buy
16,470
+8,318
+102% +$417K 0.08% 192
2013
Q3
$410K Buy
8,152
+2,783
+52% +$146K 0.05% 200
2013
Q2
$264K Buy
+5,369
New +$292K 0.03% 211

Other funds holding LLY

LS Investment Advisors's LLY Position: Q2 2026 in Review

LS Investment Advisors reduced its Eli Lilly (LLY) stake by 6.6% in Q2 2026, selling an estimated $333K and leaving 4,611 shares worth $5.53M. The position accounts for 0.75% of the portfolio, ranked #39.

LS Investment Advisors first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 1,691 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • LS Investment Advisors held 4,611 shares of Eli Lilly worth $5.53M as of Q2 2026.
  • LS Investment Advisors sold 326 Eli Lilly shares in Q2 2026, an estimated $333K.
  • Eli Lilly made up 0.75% of LS Investment Advisors's portfolio in Q2 2026, its #39 holding.
  • LS Investment Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 1,691 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on LS Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.